C07D 245/04
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D245/04 (Condensed with carbocyclic rings or ring systems) appears on 108 US grants and 111 published applications in this corpus.
Search patents in C07D- Granted patents
- 108
- Published applications
- 111
- Assignees
- 88
- Inventors
- 353
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 3 |
| 2004 | 3 | 4 |
| 2005 | 3 | 4 |
| 2006 | 1 | 1 |
| 2007 | 2 | 9 |
| 2008 | 0 | 5 |
| 2009 | 4 | 11 |
| 2010 | 5 | 6 |
| 2011 | 2 | 4 |
| 2012 | 6 | 7 |
| 2013 | 5 | 6 |
| 2014 | 7 | 4 |
| 2015 | 7 | 4 |
| 2016 | 2 | 6 |
| 2017 | 4 | 6 |
| 2018 | 2 | 5 |
| 2019 | 5 | 2 |
| 2020 | 1 | 3 |
| 2021 | 3 | 6 |
| 2022 | 3 | 1 |
| 2023 | 2 | 6 |
| 2024 | 2 | 4 |
| 2025 | 2 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ras inhibitors12 Aug 2025US 12,384,750 B2Revolution Medicines, Inc.
- Workflow for generating compounds with biological activity against a specific biological target6 May 2025US 12,293,809 B2Insilico Medicine IP Limited
- Ras inhibitors9 Apr 2024US 11,952,352 B2Revolution Medicines, Inc.
- OX2R compounds20 Feb 2024US 11,905,297 B2Board of Regents, The University of Texas System
- Ras inhibitors31 Jan 2023US 11,566,007 B2Revolution Medicines, Inc.
- Ras inhibitors12 Feb 2026US 2026/0042740 A1Revolution Medicines, Inc.
- Catalyst31 Jul 2025US 2025/0242335 A1The University of Manchester
- Workflow for generating compounds with biological activity against a specific biological target17 Jul 2025US 2025/0232847 A1Insilico Medicine IP Limited
- Ras inhibitors5 Dec 2024US 2024/0400523 A1Revolution Medicines, Inc.
- Macrocyclic chalcone-amide derived antiviral agents27 Jun 2024US 2024/0207224 A1Enanta Pharmaceuticals, Inc.
Most cited
By later US patents
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds72US 6,867,298 B2Massachusetts Institute of Technology · 2005
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds62US 7,115,784 B2Massachusetts Institute of Technology · 2006
- Protein kinase C modulators N48US 6,080,784 AProcyon Pharmaceuticals, Inc. · 2000